ҽҩ֪ʶ
ҽҩ֪ʶ
ҽҩ֪ʶ
ҽҩ֪ʶ
  • мؽ׿ͦͰľĸЧã

    201911£˱ȽCosentyx(ͦ˾ȵ׳ơս𵥿)Humira(֣ľ)ЧͰȫԵоо˳800ǰδƷƵĻмؽףPsAߡʾCosentyxHumiraҪյACR20ԽԵͳѧ죬ֵʾߵĽһԤָԷУ۲쵽CosentyxHumiraPsAյ㷽ͳѧơйCosentyxͦ®201941ջ׼Ʒϵͳƻָ

  • ҽϼ滹Թ

    ҴƬ1꼰ϻߵƣԭѪС֢(ITP)Ͽʼ6»ʱ䣬ҶЧȾij˻ߣѪС֢ѪС֢ij̶ֹάѸҪءҴƬࡶ2020ҩƷĿ¼ζŽỼƵľøһʹôҩƷĿɼԺͿɻԣ㻼߳ڡ淶Ƶø໼ߴ棬ûֳܹƣͬʱҲΪITPߴڻ档ҽ

  • ̩rάᣩ̨θЧΣӦЩ

    Ayvakitavapritinib̩rάᣩΪά/ᣬй½ƷΪ̩Blueprint Medicines˾20214£̩rάƬ̨УЯPDGFRA D842Vͻ޷гתθ˻ߡҩǻȫNAVIGATOR һٴо2020ŷҽѧѧᣨESMOϹNAVIGATORоPDGFRA D842VͻGISTݡ202039ݽֹյĽʾǰܹδܹƵPDGFRA D842V ͻ GIST 38

  • ̩ʥ棨鵥PD-L1ٰ

    գFDA֧άֿPD-L1ƷTecentriq̩ʥ棬鵥PD-L1ٰTNBCһ׼ΪTecentriqϻƣAbraxane׵׽ɼ[nab-ɼ]ƾFDA׼ļ֤ⷽʵΪPD-L1гԡֲڻתTNBCߡٰŮİ֢ͣȫÿȷﳬ200TNBCԼռ15%ȣTNBC50ŮиTecentriqPD-(L)1ƷϸϸϱPD-L1ףPD-1B7.1

  • GC4419ƣSBRTľֲٰЧGC4419ʲô

    գ绯øģGC4419avasopasem manganese밲οڽ嶨岿ƣSBRTľֲٰLAPCЧͰȫԵ1/2ٴ½ʾ밲ο+SBRTȣGC4419+SBRTӳһλOS20.1 vs 10.9£Чָ귽ҲʾԽGC4419һָѡԡǿЧС绯øģģ೬绯øĻԣɻֽΪ⡣˴ι1/2ٴһ˫äġο

  • ͯĸϸDanyelzaЧô

    ĸϸһּϮԵӤ׶֮һܽǿģʽʣҴкܸߵĸաDanyelzanaxitamab-gqgkһְ񾭽֬GD2Դ¡壬֮ǰѻFDAͻҩʸBTDGD2ԭڸ߲Դгָ߱ĸϸɫ͹DanyelzaͨGD2ԭϣܹ鵼ϸԷӦϵͳеIJϵͳӶﵽɱЧDanyelzaͨGD2һĸϸ

  • mobocertinibEGFR20ͻתԷСϸΰЧͰȫ

    գFDAڷ򿹰ҩmobocertinibTAK-788ҩ루NDAǰܹҩƲչFDA׼ļ֤ⷽʵΪƤ壨EGFR20ͻԣEGFRex20ins+תԷСϸΰmNSCLC˻ߡmobocertinib NDAһ1/2ٴĽоǰܹҩƲչЯEGFR20ͻ䣨EGFR Exon20 insertion+תԷСϸΰmNSCLCпչmobocertinibЧͰȫԡʾmobocertinibʾٴ

  • Nefeconε£IgAЧΣ

    գFDANefeconε£ҩ루NDA飬DzεµһͿڷƼҩIgA1µͨµIgA1IgAIgANNefecon NDAύNefIgArdؼ3оAֵݡһ˫äοաʶоּNefecon밲ο200IgANеЧͰȫԡ밲οȣоﵽ˼ٵҪյ㣬ʾeGFR9ʱȶύϻNEFIGAN 2ٴݣҲﵽNefIgArdоҪʹҪյ㡣

  • άحKaftrioivacaftorҩӦȺ

    άCFһֺġŴӰȫԼ7.5ˡCFһ۽ĶϵͳӰβࡢθ񼡢١ٺֳCFCFTRijЩͻ䵼CFTR׹ȱݻȱʧġͯŴ2ȱݵCFTR򣨸ĸһŻỼCFգŷίԱᣨEC׼Kaftrioivacaftor/tezacaftor/elexacaftorivacaftor 150mgƬҩǩչ12ꡢάĤ絼ӣCFTRдһF508delͻCFߡ˴αǩչ׼

  • ЩƣһƷΰЧΣ

    20205£FDA׼AlunbrigᣩΪһֵҩƷһƼܰøԣALK+תԷСϸΰNSCLC˻ߡŷˣAlunbrigڽ4³һǰûнܹALKƼALK+NSCLC˻ߡALK+NSCLCߣرЩѾתƣXalkoriȣAlunbrigһALK+NSCLCʾǿЧ­Ч֮ǰѱ׼ΪһֵҩƷǰܹcrizotinibᣬXalkoriƵALK+NSCLC˻ߡ2ãALTA 1LоʾAlunb

  • +Ƽ״ٰڹڻ𣿹ҽ

    +BRAF V600EͻļԼ״ٰ20185£FDA׼TafinlarᣩMekinistᣩBRAF V600E쳣ļԼ״ٰ430գ׼BRAFͻĺɫ֮ǰҲƴͻķСϸΰоļBRAFV600EͻĻߣ23ЧATCߵЧΪ61ȫͲַӦʷֱΪ45764Ļ߷ӦʱΪ6¡ƼΪÿտڷ150 mgᣬÿտڷһ2 mg ᡣ

  • ҩحbardoxoloneAlportۺȫԺΣ

    գFDAbardoxolone methylbardoxoloneҩ루NDAAlportۺCKDAlportۺһŴףһΣļ׼ƷNDACARDINAL 3ٴЧͰȫݡһ˫äοա飬ŷޡձͰĴǵĴԼ50оصļ157AlportۺCKDߡУ߰1:1ı䣬ÿ1οڷbardoxoloneοо2Ҫյ100ܺС˹ʣeGFR

  • ӦƤ׵Чڹڻҽ

    2021Ƥѧ飨AAD VMXϹ˿ڷJAKƼOlumiantbaricitinibᣩӦƤףADݡ202011£Olumiantŷ׼ʺϵͳƷжضAD˻ߡڶBREESE-AD5 3鿪չһУͨȻ߱仯İٷֱ밲οȣOlumiantһھͬʱADس̶ȺͷΧҪ֢״BREEZE-AD5оһºУͨ밲οȴӻ߱仯İٷֱ1ʱOlumiant

  • HER2ٰٴĿļ

    Ŀ⼰ܣTAA013 ԱϿھ鵥ʧܵġгľֲڻתHER2 ٰЧԺͰȫԵĶġƽжաűǩIII ٴооҩTAA013Ⱥ鵥ʧܵġгľֲڻתHER2 ٰߡҩTAA013 100mg/ƿżҩT-DM1Kadcyla®ͬҩҩƷᣨ׻Ƭ 250mg/ƬƬ150mg/Ƭ500mg/Ƭؼѡ׼

  • RetevmoRETͻķΰ״ٰЧô

    RETںNSCLCݣNEJMϷ£漰ǰ105ǰܹƣΣ39ǰûнܹƣΣRETںNSCLC˻ߡзƵĻϽеġʾ105λУORRΪ64%λDORΪ17.5¡39λУORRΪ85%λDORδﵽNR11ڻתƵľλУ­ڻʣCNS-ORRΪ91%n=10/11ȫ10⻼ߵ­ڻʱ䣨CNS-DOR6¡RETıļ״ٰݣNEJMϷ£漰3R

  • RetevmoƷΰЧIJӦЩ

    RetevmoһѡRETøƼܹRETøֹϸ5£RetevmoFDA׼RETڻı䣨ͻںϣ3ߣNSCLC״MTC͵ļ״ٰԣҩ׼ƣ1ڻתNSCLC˻ߣ212ꡢҪϵͳƵڻתMTCߣ312ꡢҪϵͳơԷԵֹͣӦʺϷԵƵRETںԼ״ٰߡֵһǣߴ50%RETںNSCLC߿ܴ

  • RETøƼRetevmo3ЧΣRetevmo˵

    ݹƣRETںϴڴԼ2%ķСϸΰNSCLC10-20%ͷ״״ٰPTCͼ״ٰԼֱ֢УRETͻڴԼ60%ļ״MTCСRETںϼRETͻ䰩֢ҪRETøļάֳʹͨΪ°񫡱ʹ԰RETСƼ߶СRetevmoǵһ׼רЯRETıİ֢ߵҩǰܶRETͻķֻٰ֪ãж֢İҩˣRetevmoΪһָ

  • ϰƶѪߵЧΣϼҩУ

    -ҴƬйʳƷҩƷල(CFDA)׼йʽСйһҲΨһ׼ĿڷСӷTPO弤ڳ˺12϶ͯѪС֢ܿѪС壬ҲӦ٣÷㣬˻ߵЧҩԣΪٴҽͻߴµѡ񡣡ϰƶѪЧôƷ150mg/գ24ܣ꣩40ϻ߲μ顣Чҩ꣬20û⣨50%

  • ˹ưۺЧʲôǰ

    ҲΪۺ1937ҽѧҷֵһּѪ׵һֺ֡٣ǻƤؽڼ⡢۾ѪܡࡢκϵͳȣҪٴΪǻͻƤ۲ĤסʳС᳦񼰹ؽʹȡǻ֢״С񣬽ΪɷڴࡢաȲλһ10ҿϡ˹һֿڷСø-4ƼڢоУҩɽͰۺ߿ǻķʺس̶ȡ

  • deucravacitinibмٴЧܰOtezlaȫԺΣ

    20214£2021Ƥѧ飨AAD VMXϹͿҩdeucravacitinibBMS-986165жضȰ߿мߵ2ؼ3оPOETYK PSO-1POETYK PSO-2ԽPOETYK PSO-1NCT03624127POETYK PSO-2NCT036117512ȫ3ожضȰ߿мпչּdeucravacitinib6mgÿһΣڰοOtezlaapremilastİȫԺЧԡ2оΪġ˫ä飬ֱ6661020ߣdeucravacitinib

共有195页首页上一页123456789下一页尾页
客服中心
联系方式
400-001-9763
- ѯ
ɨһɨѯ